Expert: Dual agonist of GLP-1 and GIP receptors, providing synergistic effects on glucose homeostasis, appetite suppression, and weight loss through central and peripheral mechanisms.
Everyday: Mimics two gut hormones that regulate appetite and blood sugar. Helps people feel full and improves how the body processes sugar.
Tirzepatide, a dual GLP-1 and GIP receptor agonist for type 2 diabetes. First-in-class dual incretin agonist; demonstrated superior glycemic control and weight loss vs GLP-1 agonists alone; weekly SC injection.